RMD Instruments and Cunningham Woodland Announce Distribution Agreement for Navigator System and Surgical Probes.
August 16 2010 - 10:00AM
Business Wire
RMD Instruments Corp, a wholly owned subsidiary of Dynasil
Corporation of America (OTCBB:DYSL) today announced that they and
Cunningham Woodland, Inc. a leading specialty surgical supply
company, have entered into an agreement whereby Cunningham will
handle exclusive New England distribution of RMD’s Navigator™
system and gamma surgical probes for advanced cancer detection and
evaluation, which help doctors more accurately locate cancer cells
for targeted therapy.
Mark Caldwell, General Manager of RMD, commented “We are excited
that Cunningham Woodland is distributing our Navigator™ GPS line of
products which provides gamma localization of tissue during
surgery. The system and mapping probes are intended for use in
localizing suspected cancer lesions not visible with other imaging
modalities, providing early detection and evaluation of disease
extent. We think the combination of their reputation and marketing
horsepower, together with our Navigator GPS product line, will be a
winning combination in this critical segment of the cancer surgery
market.”
“Cunningham has been serving the New England market for over 25
years and is a respected distributor in this important region,”
added Jim Lovejoy, General Sales Manager, of RMD’s medical
products. “Their present product portfolio and positive reputation
in the surgical community, including relationships with the
operating room personnel, heads of specialties, and key surgeons,
is a good match for the Navigator™ product line.”
“We are thrilled to be representing a local manufacturer with
state of the art technology, extensive research and development and
a product line that benefits both the patient and the surgeon,”
stated George Woodland, President of Cunningham Woodland, Inc.
About RMD Instruments Corp.:
RMD Instruments Corp (RMD), a wholly owned subsidiary of Dynasil
Corporation of America, is a diversified technology company
providing innovative products to a wide range of markets and
disciplines. The company has a rich history of applying science and
research to develop products that improve healthcare, enhance
security and deliver advanced solutions to businesses around the
world. RMD has been producing the Navigator™ GPS Lymphatic Mapping
System since 1999. RMD is based in Watertown, Massachusetts.
About Dynasil: Dynasil Corporation of America (OTCBB:
DYSL), is a provider of technology, products, services and
solutions aimed at making the world safer and healthier. The
company supplies a broad range of customers by serving their
specific needs in the medical, industrial, and homeland
security/defense markets. The Company has operations in New Jersey,
New York, Massachusetts and the UK.
This news release may contain forward-looking statements usually
containing the words "believe," "expect," “plan”, “target”,
“intend” or similar expressions. These statements are made pursuant
to the safe harbor provisions of the Private Securities Litigation
Reform Act. Future results of operations, projections, and
expectations, which may relate to this release, involve certain
risks and uncertainties that could cause actual results to differ
materially from the forward-looking statements. Factors that would
cause or contribute to such differences include, but are not
limited to, the factors detailed in the Company's Annual Report or
Form 10-K and in the Company's other Securities and Exchange
Commission filings, continuation of existing market conditions and
demand for our products. Dynasil undertakes no obligation to update
these forward-looking statements to reflect actual results, changes
in assumptions or changes in other factors that may affect such
forward-looking statements
Dynasil Corp of America (CE) (USOTC:DYSL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Dynasil Corp of America (CE) (USOTC:DYSL)
Historical Stock Chart
From Jul 2023 to Jul 2024